Molecular biology of exocrine pancreatic cancer

José Luis Soto, Víctor Manuel Barbera, Miguel Saceda, Alfredo Carrato

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

3 Citas (Scopus)


Exocrine pancreatic cancer is one of the neoplasias with a worse prognosis, with conventional treatments having little impact on disease outcome. Research and genomic high-throughput technology is continuously expanding our knowledge of pancreas cancer biology. Characterization of genetic and epigenetic alterations in pancreatic tumors has allowed a better understanding of the progression model of the disease at the molecular level. The development of new therapeutic approaches with target-oriented agents is been tested in the preclinical and clinical settings. This review updates the current available data on pancreatic cancer molecular biology.

Idioma originalInglés
Páginas (desde-hasta)306-312
Número de páginas7
PublicaciónClinical and Translational Oncology
EstadoPublicada - 2006
Publicado de forma externa


Profundice en los temas de investigación de 'Molecular biology of exocrine pancreatic cancer'. En conjunto forman una huella única.

Citar esto